Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Kempharm Inc
(NQ:
KMPH
)
9.698
USD
+0.988 (+11.34%)
Streaming Delayed Price
Updated: 2:43 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Kempharm Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Kempharm Scores Relative Strength Rating Upgrade
February 17, 2021
Kempharm sees its Relative Strength Rating hit the elite 90-plus level.
From
Investor's Business Daily
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?
February 16, 2021
InvestorsObserver issues critical PriceWatch Alerts for SLRX, KMPH, OCUL, BOXL, and NDRA.
From
PR Newswire
InvestorNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Secures $52.4M in Follow-on and $44M in Warrant Exchange Transaction
February 12, 2021
From
InvestorBrandNetwork
Kempharm Scores Relative Strength Rating Upgrade
February 11, 2021
A Relative Strength Rating upgrade for Kempharm shows improving technical performance.
From
Investor's Business Daily
105 Biggest Movers From Yesterday
February 09, 2021
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares jumped 201.1% to close at $15.81 on Monday after announcing the sale of 3 million ...
Tags
SNPR
CLNE
CLSN
From
Benzinga
70 Stocks Moving In Monday's Mid-Day Session
February 08, 2021
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares climbed 183.2% to $14.87 after announcing the sale of 3 million common shares at $7.65 ...
Tags
BTBT
LIZI
GOVX
From
Benzinga
48 Stocks Moving in Monday's Pre-Market Session
February 08, 2021
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares rose 96.4% to $13.63 in pre-market trading. Nemaura Medical last week appointed ...
Tags
Small Cap
METX
BEST
From
Benzinga
KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Use Disorder
January 27, 2021
From
GlobeNewswire News Releases
100 Biggest Movers From Yesterday
January 27, 2021
Gainers EZGO Technologies Ltd(NASDAQ: EZGO) shares jumped around 352.8% to close at $18.11on Tuesday after the company ...
Tags
AUPH
TPGY
MG
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 26, 2021
Gainers AIkido Pharma (NASDAQ:AIKI) stock moved upwards by 49.94% to $1.83 during Tuesday's regular session. The ...
Tags
AIKI
Markets
CAPR
From
Benzinga
55 Stocks Moving In Tuesday's Mid-Day Session
January 26, 2021
Gainers Oxbridge Re Holdings Limited (NASDAQ: OXBR) gained 65% to $3.96. Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 62.6% ...
Tags
Mid/Day Movers
OEG
ENG
From
Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
January 26, 2021
Gainers Koss Corporation (NASDAQ: KOSS) shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the ...
Tags
GOVX
AUPH
ECOR
From
Benzinga
84 Biggest Movers From Yesterday
January 26, 2021
Gainers Express, Inc. (NYSE: EXPR) shares surged 131.8% to close at $4.15 on Monday amid increased interest from retail investor ...
Tags
MBIO
CYRX
Trading Ideas
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 25, 2021
Gainers VYNE Therapeutics (NASDAQ:VYNE) shares moved upwards by 37.5% to $2.58 during Monday's regular session. ...
Tags
BNGO
GRTS
CYRX
From
Benzinga
61 Stocks Moving In Monday's Mid-Day Session
January 25, 2021
Gainers Aemetis, Inc. (NASDAQ: AMTX) climbed 117.3% to $9.56. Aemetis shares gained over 9% on Friday after the company announced ...
Tags
FIZZ
RKDA
SESN
From
Benzinga
KMPH August 20th Options Begin Trading
January 21, 2021
Investors in KemPharm Inc (KMPH) saw new options become available today, for the August 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...
Tags
Stocks
From
Market News Video
KemPharm’s KP415 and Serdexmethylphenidate (SDX) Prodrug to be Featured in Multiple Sessions at the 2021 APSARD Virtual Conference
January 14, 2021
From
GlobeNewswire News Releases
KemPharm Participating in BIO @ JPM and Fierce JPM Week 2021 Virtual Events During “J.P. Morgan Week 2021”
January 13, 2021
From
GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Monday
January 11, 2021
This morning 127 companies reached new 52-week highs. Noteworthy Mentions: Johnson & Johnson (NYSE: JNJ) was the ...
Tags
JNJ
SLM
GDS
From
Benzinga
82 Biggest Movers From Friday
January 11, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 177% to close at $2.13on Friday after the company announced ...
Tags
DRIO
APDN
WDFC
From
Benzinga
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
January 08, 2021
From
GlobeNewswire News Releases
KemPharm Announces 1-For-16 Reverse Stock Split
December 27, 2020
Shares of the Company’s common stock are expected to begin trading on a split-adjusted basis on Monday, December 28, 2020. The Reverse Stock Split is intended to enable the Company to potentially...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
KemPharm Announces 1-for-16 Reverse Stock Split
December 23, 2020
From
GlobeNewswire News Releases
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
December 22, 2020
From
GlobeNewswire News Releases
KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
December 02, 2020
From
GlobeNewswire News Releases
REMINDER: KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
November 30, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
LMAT
STIM
SWAV
From
Benzinga
KemPharm Provides Update on Development Pipeline
November 23, 2020
From
GlobeNewswire News Releases
KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
November 18, 2020
From
GlobeNewswire News Releases
KemPharm Reports Third Quarter 2020 Financial Results
October 29, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.